Phase 4 Migraine Clinical Trials
17 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–17 of 17 trials
Recruiting
Phase 4
Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
Migraine
Mayo Clinic1,335 enrolled23 locationsNCT06972056
Not Yet Recruiting
Phase 4
Sphenopalatine Nerve Ganglion Block for Acute Benign Headaches in the Emergency Department: A Pilot Randomized Controlled Trial
benign headaches (e.g. migraine)
The Ottawa Hospital Research Institute175 enrolled1 locationACTRN12626000229370
Recruiting
Phase 4
Rimegepant as Preemptive Treatment for Predictable Trigger-Induced Migraine in Adult Patients in the US
MigraineTrigger Induced Migraine
Medstar Health Research Institute60 enrolled1 locationNCT07301008
Recruiting
Phase 4
A Comparison of Nurtec ODT to Maxalt MLT-ODT in Adult ED Patients With Migraine Headache
Migraine
Antonios Likourezos80 enrolled1 locationNCT06473597
Recruiting
Phase 4
Effectiveness and Tolerability of Zavegepant for Acute Migraine Treatment Among Those Using CGRP Targeting Preventive Medications
Migraine
Mayo Clinic200 enrolled1 locationNCT06401642
Recruiting
Phase 4
Evaluation of Efficacy and Safety of Topical Cannabidiol (Canvert-M Produced by Alasht Pharmed co. Iran) in the Treatment of Migraine Attacks
Migraine Disorders
Alasht Pharmed30 enrolled1 locationNCT07093138
Recruiting
Phase 4
Acute Migraine Treatment in the ED With Gepants
Migraine Headaches
Icahn School of Medicine at Mount Sinai100 enrolled1 locationNCT06985342
Recruiting
Phase 4
Assessment of Oral Caffeine Intake in Changing the Severity of Acute Migraine Attack Using VAS Score Among Patients Attending Headache and Neurology Outpatients Clinic of Ainshams University Hospitals
MigraineMigraine Disease
Ain Shams University120 enrolled1 locationNCT07022496
Recruiting
Phase 4
Qudexy XR for the Prevention of Migraine in Children 6 to 11 Years Old
Migraine Disorders
Upsher-Smith Laboratories132 enrolled15 locationsNCT04748601
Recruiting
Phase 4
Migraine and High Flow Oxygenotherapy at the Emergency Department (MiOx)
Migraine
Centre Hospitalier Universitaire de Nice70 enrolled1 locationNCT04925414
Recruiting
Phase 4
Impact of Combined Oral Contraceptive Pills on Migraine
Migraine
Kafrelsheikh University400 enrolled1 locationNCT06509503
Recruiting
Phase 4
Valproate Versus Propranolol in Migraine
Migraine Disorders
Kafrelsheikh University600 enrolled1 locationNCT06485726
Recruiting
Phase 4
An evaluation of the efficacy of eptinezumab in the inpatient management of status migrainosus in comparison to intravenous lignocaine in patients who have failed other therapies
Migraine
Alfred Health40 enrolled1 locationACTRN12621001616864
Recruiting
Phase 4
Propofol for Migraine Treatment in Emergency Department
Migraine
Emergency & Trauma Centre, The Alfred Hospital40 enrolled1 locationACTRN12619001595101
Terminated
Phase 4
The STELAR trial: Intravenous stemetil versus intravenous largactil for the treatment of acute migraine in adults
Migraine
Sarah Hodgson70 enrolled1 locationACTRN12618000138280
Terminated
Phase 4
Pilot phase for the workplace migraine HeadAche Prevention Project (HAPPy - pilot) to investigate in a double blind randomised factorial trial whether treatment with low-dose combination blood pressure (BP) and cholesterol lowering therapy will reduce migraine compared to standard therapy and placebo.
Migraine
The George Institute for Global Health180 enrolled2 locationsACTRN12616000937415
Completed
Phase 4
Does a single oral dose of dexamethasone after successful emergency department treatment of migraine reduce the incidence or severity of rebound headache within 48 hours?
Migraine
The Joseph Epstein Centre for Emergency Medicine Research76 enrolled1 locationACTRN12605000034639